Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel
Israel: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.1% in 2024. ◆ Volatile
Latest (2024)
0.1%
Change on year
unchanged
World rank
135th
of 247 countries
All-time high
0.4%
in 2015
All-time low
0.1%
in 2020
Years of data
10
2015–2024
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Israel recorded 0.1% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
The figure is down 75.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Israel peaked at 0.4% in 2015 and was at its lowest, 0.1%, in 2020.
That places Israel 135th out of 247 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Israel, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.3% | -25.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.2% | -33.3% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.1% | -50.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.1% | +0.0% |
Israel compared with similar countries
- Israel's 0.1% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 0.1%, 1.0× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.4% | 5 |
| 2020s | 0.1% | 0.1% | 0.1% | 5 |
Countries ranked near Israel
- 135 Albania 0.1% compare
- 135 Algeria 0.1% compare
- 135 Armenia 0.1% compare
- 135 Australia 0.1% compare
- 135 Belize 0.1% compare
- 135 Bhutan 0.1% compare
- 135 Bolivia (Plurinational State of) 0.1% compare
- 135 China 0.1% compare
- 135 Denmark 0.1% compare
- 135 Dominican Republic 0.1% compare
- 135 Gambia 0.1% compare
- 135 Guam 0.1% compare
- 135 Guyana 0.1% compare
- 135 Hungary 0.1% compare
- 135 Jordan 0.1% compare
- 135 Kyrgyzstan 0.1% compare
- 135 Lebanon 0.1% compare
- 135 Lithuania 0.1% compare
- 135 Malaysia 0.1% compare
- 135 Oman 0.1% compare
- 135 Paraguay 0.1% compare
- 135 Peru 0.1% compare
- 135 Romania 0.1% compare
- 135 Russian Federation 0.1% compare
- 135 Serbia 0.1% compare
- 135 Singapore 0.1% compare
- 135 Thailand 0.1% compare
- 135 Trinidad and Tobago 0.1% compare
- 135 Tunisia 0.1% compare
- 135 Ukraine 0.1% compare
- 135 Uzbekistan 0.1% compare
- 135 Russia 0.1% compare
More development goals data for Israel
- Red List Index 0.6521 (2025)
- Number of refugees per 100,000 population, by country of origin 13.35 (2025)
- Manufacturing value added per capita 6,053 (2025)
- Number of transboundary breeds 9 (2025)
- Number of transboundary breeds (not extinct) 9 (2025)
- Number of transboundary breeds with unknown risk status 9 (2025)
- Number of local breeds with unknown risk status 3 (2025)
- Number of local breeds (not extinct) 3 (2025)
- Number of local breeds kept in the country 3 (2025)
- Infant deaths 457 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Israel?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Israel was 0.1% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Israel?
- The highest recorded value was 0.4% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Israel?
- The lowest recorded value was 0.1% in 2020.
- How does Israel rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Israel ranks 135th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Israel?
- Over the last ten years it is down 75.0%. The long-run trend across the full record is volatile.
- Where does this Israel data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).